Master of Science in Cancer Pharmacology

London Metropolitan University - Holloway Campus

UK,England

 0 Shortlist

12 Months

Duration

CAD 16,500/year

Tuition Fee

CAD 0 FREE

Application Fee

Apply Date

UK, England

Type: University

Location Type: Urban

Founded: 2002

Total Students: 12,525 +

Campus Detail

Main Campus Address

166-220 Holloway Rd, London N7 8DB, United Kingdom

Master of Science in Cancer Pharmacology

Program Overview

London Met’s Cancer Pharmacology master's course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers.

With worldwide cancer rates increasing and expected to reach 22 million new cases per year by 2030, this postgraduate course introduces you to how radiotherapy, surgery and chemotherapy have a vital role to play in prolonging the lives of patients.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving. You’ll also review the biology of cancer with respect to genetics, pathological considerations and the molecular changes within cells which are associated with the progression of the disease.

You'll be taught by staff who are experienced researchers in areas such as cancer biology,  immunology, genetics and bioinformatics. They will help you learn how to collect, analyse, interpret and understand scientific data you must make use of in the cancer pharmacology field. This ensures you’ll not only improve your intellectual knowledge but your practical skills as well.